Literature DB >> 15086843

Parachordoma is not distinguishable from axial chordoma using immunohistochemistry.

Richard A Scolyer1, S Fiona Bonar, A Allan Palmer, Elizabeth M Barr, Edward J Wills, Paul Stalley, Julie Schatz, Judith Soper, Ling-Xi L Li, Stanley W McCarthy.   

Abstract

Parachordoma is a rare soft tissue tumor that morphologically resembles chordoma of the axial skeleton but occurs in a peripheral site. A recent study reported immunohistochemical differences between chordoma and parachordoma. While both tumors were positive for cytokeratin (CK) 8/18 (as recognized by the antibody Cam5.2), S100 and epithelial membrane antigen (EMA), only the chordoma was positive for CK7, CK20, CK 1/5/10/14 (as recognized by the antibody 34betaE12) and carcinoembryonic antigen (CEA). It has since been suggested that tumors indistinguishable from chordoma that involve the periphery should be termed chordoma periphericum and that these tumors are distinct from parachordoma. In the current study, the clinical, radiological, pathological, immunohistochemical and ultrastructural features of a chordoma-like tumor involving the deep soft tissues of the lower leg of a 69-year-old woman are presented. Microscopically, the tumor had a pseudolobulated growth pattern and consisted of sheets, nests and cords of epithelioid cells, some with a physaliferous appearance, separated by abundant myxoid stroma. The tumor cells were positive for CK 8/18, EMA and S100, showed focal staining for CK7, and were negative for CK20, CK 1/5/10/14 and CEA. On the basis of these results a diagnosis of parachordoma was favored. For comparison, an immunohistochemical analysis of five axial chordomas was also performed. The chordomas showed positivity for CK 8/18 (5 of 5 cases), EMA (5 of 5 cases), S100 (5 of 5 cases), CK 1/5/10/14 (1 of 5 cases) and CK7 (1 of 5 cases). Stains for CK20 and CEA were negative in all five chordomas. The results of the present study suggest that the expression of antigens for CK 1/5/10/14, CK7, CK20 and CEA in chordoma might not be as common as what has been previously reported. The results also suggest that parachordoma might not be easily distinguished immunohistochemically from axial chordoma (and therefore also from so-called chordoma periphericum).

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15086843     DOI: 10.1111/j.1440-1827.2004.01633.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  5 in total

Review 1.  Intra-articular extra-axial chordoma of the wrist: a case report with review of the current literature.

Authors:  Jan Neumann; Alexandra S Gersing; Thomas F Barth; Melanie Boxberg; Klaus Woertler
Journal:  Skeletal Radiol       Date:  2019-05-18       Impact factor: 2.199

2.  Diagnosing an extra-axial chordoma of the proximal tibia with the help of brachyury, a molecule required for notochordal differentiation.

Authors:  Paul O'donnell; Roberto Tirabosco; Sonja Vujovic; William Bartlett; Timothy W R Briggs; Stephen Henderson; Chris Boshoff; Adrienne M Flanagan
Journal:  Skeletal Radiol       Date:  2006-06-30       Impact factor: 2.199

3.  EWSR1-POU5F1 fusion in soft tissue myoepithelial tumors. A molecular analysis of sixty-six cases, including soft tissue, bone, and visceral lesions, showing common involvement of the EWSR1 gene.

Authors:  Cristina R Antonescu; Lei Zhang; Ning-En Chang; Bruce R Pawel; William Travis; Nora Katabi; Morris Edelman; Andrew E Rosenberg; G Petur Nielsen; Paola Dal Cin; Christopher D M Fletcher
Journal:  Genes Chromosomes Cancer       Date:  2010-12       Impact factor: 5.006

4.  Primary intestinal and vertebral chordomas in laboratory zebrafish (Danio rerio).

Authors:  T K Cooper; K N Murray; S Spagnoli; J M Spitsbergen
Journal:  Vet Pathol       Date:  2014-06-09       Impact factor: 2.221

5.  Histochemical and immunohistochemical characterization of chordoma in ferrets.

Authors:  Takeshi Yui; Tetsuo Ohmachi; Kazuya Matsuda; Minoru Okamoto; Hiroyuki Taniyama
Journal:  J Vet Med Sci       Date:  2015-01-08       Impact factor: 1.267

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.